Nephrology
Chronic kidney disease, dialysis and access, transplantation, glomerular disease, acute kidney injury, diabetic kidney disease and renal hypertension.
Published issues
- What's next in nephrology — November 18, 2026
This issue covers six dated milestones between late November 2026 and the second quarter of 2027: two upcoming FDA target action dates (PDUFA) (povetacicept and imlifidase), a new PDUFA target date for a phosphate…
🎧 ListenAudio newscast · 5:04 min - Monthly nephrology bulletin — November 8, 2026
Period covered: October 9 to November 8, 2026. The month was dominated by ASN Kidney Week (Denver, October 22–25): four phase 3 trials in IgA nephropathy, a new FDA accelerated approval, and several negative pragmatic…
🎧 ListenAudio newscast · 6:27 min - What's next in nephrology — October 18, 2026
This issue covers what is coming in nephrology between the third week of October 2026 and April 2027: two phase 3 presentations at ASN Kidney Week (Denver, October 22–25), the public review of the KDIGO CKD guideline…
🎧 ListenAudio newscast · 4:51 min - Monthly nephrology bulletin — October 8, 2026
Period covered: September 8 to October 8, 2026. The month was dominated by regulatory decisions in glomerular disease (iptacopan in Japan, obinutuzumab in nephrotic syndrome), by final two-year atacicept data in IgA…
🎧 ListenAudio newscast · 6:40 min - Monthly nephrology bulletin — September 29, 2026
Monthly nephrology bulletin covering verified advances from August 30 to September 29, 2026. Note for the month: it was a strong month for regulatory decisions (two FDA approvals) and glomerular disease, and a thin one…
🎧 ListenAudio newscast · 5:57 min